Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.950
+0.2903.79%
Volume:156.67M
Turnover:1.24B
Market Cap:91.60B
PE:19.70
High:8.040
Open:7.750
Low:7.690
Close:7.660
52wk High:11.454
52wk Low:4.152
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.84
T/O Rate:1.36%
Dividend:0.25
Dividend Rate:3.10%
EPS(LYR):0.404
ROE:10.83%
ROA:5.65%
PB:2.52
PE(LYR):19.70
PS:3.22

Loading ...

Executive Director Fined 5 Million Yuan for Insider Trading, CSPC PHARMA Assures Normal Operations

Deep News
·
Nov 03

BRIEF-Cspc Pharmaceutical Says Executive Director Received "Decision On Administrative Penalty"

Reuters
·
Nov 03

CSPC Innovation Suspends Trading Amid Proposed Acquisition and Fundraising

Reuters
·
Nov 03

CSPC Pharmaceutical - Executive Director Received "Decision on Administrative Penalty" Issued by Csrc

THOMSON REUTERS
·
Nov 03

CSPC Pharmaceutical - Csrc Ordered Exec Director to Deal With Illegally Held Securities in Accordance With Law, and Imposed Fine of RMB5 Mln

THOMSON REUTERS
·
Nov 03

Did CSPC’s siRNA and ADC Regulatory Wins Just Shift Its (SEHK:1093) Investment Narrative?

Simply Wall St.
·
Nov 03

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After Latest Regulatory Milestones and R&D Pipeline Advances

Simply Wall St.
·
Nov 01

CSPC Pharmaceutical Group Stock Rises 2.4% in Hong Kong

Dow Jones
·
Oct 31

CSPC Pharmaceutical Group Stock Sheds 2.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 30

HK Stock Connect Shareholding Changes as of October 30

Stock News
·
Oct 30

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28

CSPC Pharmaceutical Group (1093.HK) Subsidiary CSPC Innovation (300765.SZ) Releases 2025 Third Quarter Results

Bulletin Express
·
Oct 27

CSPC PHARMA (01093): CSPC Innovation Pharmaceutical (300765.SZ) Reports Net Loss of RMB24.05 Million in First Three Quarters

Stock News
·
Oct 27

CSPC Pharmaceutical Group Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Oct 27

Short Selling Statistics of Hong Kong Stocks | October 27

Stock News
·
Oct 27

Capital Flow Statistics of Hong Kong Stock Connect (T+2) | October 27

Stock News
·
Oct 27

BRIEF-CSPC Pharmaceutical Says SYH2061 Injection Obtains Clinical Trial Approval In China

Reuters
·
Oct 24

CSPC Pharma Gets China Nod for IgA Nephropathy Drug Trial

MT Newswires Live
·
Oct 24

Active Trading on Hong Kong Stock Connect | October 24

Stock News
·
Oct 24

CSPC Pharmaceutical Group (1093.HK) Receives Clinical Trial Approval for SYH2061 Injection

Bulletin Express
·
Oct 24